Bioserve is a dynamic biotechnology organization primarily centered on clinical diagnostics solutions to answer vital questions about early Cancer diagnosis. We are India's leading Oligosynthesis service provider and have a strong foothold in Molecular services as well.

With 20+ years of excellence in offering quality services to major academic institutions and clinical diagnostic labs, we have established a great customer base across the country. Bioserve has recently been acquired by the Reprocell Group (a JASDAQ listed company), headquartered in Japan with corporate offices in the Europe, USA and India. Through the acquisition, our capacities are further expanded and strengthened for a plethora of services like nucleic acid processing, classic sanger sequencing, advanced next generation sequencing, gene expression analysis, genotyping etc.